Registered Nurse in Toccoa, GA Accepting Medicare

5 Registered Nurse nurses found. Showing 1 - 5

Mrs. Penny Laine Roberson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 N Boulevard, Toccoa, GA 30577 Phone: 706-282-4507    Fax: 706-282-4511

Donna K Cisson, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 North Boulevard, Toccoa, GA 30577 Phone: 706-282-4507    Fax: 706-282-4511

Mrs. Karen Hiatt Palmer, R.N. Registered Nurse - Community Health Medicare: Not Enrolled in Medicare Practice Location: 222 N Boulevard, Toccoa, GA 30577 Phone: 706-282-4507    Fax: 706-282-4511

Mrs. Nancy Carol Khoury, R.N. Registered Nurse - Obstetric, High-Risk Medicare: Not Enrolled in Medicare Practice Location: 305 Norwood Ave, Toccoa, GA 30577 Phone: 706-886-5307

Mrs. Jennifer Adams Gastley, RN Registered Nurse Medicare: Not Enrolled in Medicare Practice Location: 222 N Boulevard, Toccoa, GA 30577 Phone: 706-282-4507    Fax: 706-282-4511

News Archive

Advaxis reports 3-year survival data from its ADXS11-001 Phase I trial for cervical cancer

The Phase I trial of ADXS11-001, the lead vaccine candidate of Advaxis, Inc., the company that pioneered the live, attenuated Listeria monocytogenes (Lm) vaccine, has shown thirty-six (36) month survival in two (2) of the thirteen (13) evaluable patients treated with Advaxis' therapeutic cancer vaccine, indicating the possibility of persistent immune protection, from only a two (2) dose initial regimen.

FDA approves antidepressant Cymbalta (duloxetine HCl) for treatment of generalized anxiety disorder

Eli Lilly and Company announced today that the U.S. Food and Drug Administration (FDA) has approved the antidepressant Cymbalta (duloxetine HCl) for the treatment of generalized anxiety disorder (GAD), a condition that affects more than 6.5 million American adults in a given year.

GlaxoSmithKline response to JAMA article on ICES retrospective analysis

The following is GlaxoSmithKline's response to the retrospective analysis by the Institute for Clinical Evaluative Sciences (ICES) titled "Thiazolidinediones and Cardiovascular Outcomes in Older Patients with Diabetes".

Manipulation of the body's own natural killer cells to destroy cells containing the HIV virus

Current treatments for HIV block the virus from replicating, but don't kill the cells that contain HIV. The existence of these HIV-harboring cells - often called the "latent" or "resting reservoir" - is regarded by many to be the main obstacle to finding a cure for HIV.

LSI announces publication of Emerging Medtech Companies report

Life Science Intelligence, a leading medical technology market intelligence firm, has announced the publication of its Report on Emerging Medtech Companies in Q1 2011.

Read more Medical News

› Verified 2 days ago